Medscape Medical NewsAll articles

Acumen Hypotension Prediction Index (HPI) Feature Software

Edwards Lifesciences LLC • Cardiovascular • 03/16/2018

De NovoIEC 62304 Class C
FDA Summary PDF

Device Purpose

The Acumen Hypotension Prediction Index (HPI) employs a machine-learning algorithm to continuously analyze arterial blood pressure waveforms, providing an early warning score to predict and preemptively manage impending hypotensive events in surgical patients. This technology aims to reduce intraoperative hypotension by enabling timely interventions, thereby enhancing patient safety and improving care during surgical procedures.

Summary

The Acumen Hypotension Prediction Index (HPI) is a sophisticated system designed to enhance patient safety during surgery by prospectively identifying individuals at risk of hypotension. Utilizing a machine-learning algorithm, the HPI continuously analyzes arterial blood pressure waveforms from surgical patients. Its core function is to predict the likelihood of a patient's mean arterial pressure (MAP) dropping below 65 mmHg for at least one minute, presenting this risk as a numerical score from 0 to 100. This allows anesthesiologists to receive an early warning, enabling preemptive interventions such as administering fluids or vasopressors to stabilize blood pressure before a hypotensive event fully materializes. Clinical research supports the HPI's efficacy, demonstrating strong predictive capabilities with approximately 88% sensitivity and 92% specificity in forecasting hypotensive episodes 5 to 15 minutes before their onset. Integrated into existing hemodynamic monitors, the HPI serves as a crucial supplementary early-warning tool. The ultimate goal of this technology is to significantly reduce the incidence of intraoperative hypotension by providing medical staff with timely alerts, thereby facilitating proactive patient management and potentially improving surgical outcomes.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

Acumen Hypotension Prediction Index (HPI)Machine LearningArterial Blood PressureSurgical PatientsMean Arterial Pressure (MAP)Hypotensive EventSensitivitySpecificityHemodynamic MonitorsIntraoperative Hypotension

Device Metadata

Submission Number
DEN160044
Company
Edwards Lifesciences LLC
Panel
Cardiovascular
Product Code
N/A
Data Type
Signals
Clinical Function
Assessment
AI Function
Analysis
AI Subclass
predictive

Relevant Clinical Questions

  • Q1. How does the specific machine-learning algorithm used by HPI differentiate between transient MAP fluctuations and true impending hypotensive events?; What is the training dataset size and diversity for the HPI algorithm, and how does it account for variations across different patient populations or surgical types?; Beyond sensitivity and specificity, what is the positive predictive value (PPV) and negative predictive value (NPV) of HPI in real-world clinical settings with varying hypotension prevalence?; Are there identified patient characteristics or clinical scenarios where the HPI's predictive accuracy is notably higher or lower?; What are the computational requirements for real-time arterial waveform analysis, and how does the system handle potential signal artifacts or noise?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via De Novo pathway; IEC 62304 Class C (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score20/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment⚠ Not mentioned in summary
Postmarket Plan✓ Detected in Summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(training data, machine learning, algorithm, dataset)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials
- Not detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Not detected in AI-generated device summary: SBOM, SaaSBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
Acumen Hypotension Prediction Index (HPI) Feature Software - Edwards Lifesciences LLC | ESL FDA AI Device Intelligence